1 minute read
Jan. 17, 2022
Compound 22: a CNS-Penetrant ELOVL1 Inhibitor
“compound 22”
ELOVL1 fatty acid elongase inhibitor on-target toxicity suggested from HTS and property-based optimization Journal of Medicinal Chemistry Vertex, Boston, MA
Loading...
